Compare GRFS & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | AG |
|---|---|---|
| Founded | 1940 | 1979 |
| Country | Spain | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.9B |
| IPO Year | 2006 | N/A |
| Metric | GRFS | AG |
|---|---|---|
| Price | $8.92 | $15.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $10.30 | ★ $14.25 |
| AVG Volume (30 Days) | 667.0K | ★ 16.1M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 1.60% | 0.13% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.64 | 0.16 |
| Revenue | ★ $8,821,017,248.00 | $965,571,000.00 |
| Revenue This Year | $5.46 | $107.63 |
| Revenue Next Year | $5.60 | $18.81 |
| P/E Ratio | ★ $17.34 | $95.05 |
| Revenue Growth | 7.31 | ★ 83.84 |
| 52 Week Low | $6.19 | $5.09 |
| 52 Week High | $11.14 | $16.28 |
| Indicator | GRFS | AG |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 64.52 |
| Support Level | $7.64 | $14.88 |
| Resistance Level | $8.90 | $16.28 |
| Average True Range (ATR) | 0.27 | 0.83 |
| MACD | 0.07 | 0.43 |
| Stochastic Oscillator | 92.00 | 77.61 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.